Zoll Shifts Focus From Defib To Perfusion For Cardiac Emergency Market
This article was originally published in The Gray Sheet
Executive Summary
Forthcoming American Heart Association guidelines on emergency cardiac resuscitation will spur demand for Revivant's AutoPulse, according to Zoll Medical
You may also be interested in...
Deca-Medics Plans CPR-Assist Device 510(k) Submission By Summer 2011
Deca-Medics plans to file a 510(k) within six months for its LifeBelt CPR mechanical assist device.
Deca-Medics Plans CPR-Assist Device 510(k) Submission By Summer 2011
Deca-Medics plans to file a 510(k) within six months for its LifeBelt CPR mechanical assist device.
Zoll Takes Aim At Hospital Defibrillator Market In 2007; Stock Up 131% In ’06
External defibrillator maker Zoll Medical's success in the pre-hospital emergency medical services market in 2006, and prospects for its advanced R Series defibrillator in the hospital sector in 2007, helped to hearten investors last year and propel the firm's stock price ahead 131%